Hui Yao Selected Research

DNA (Deoxyribonucleic Acid)

1/2017	Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.
1/2017	Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray.
11/2015	Factors affecting the success of next-generation sequencing in cytology specimens.
1/2015	Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system.
1/2013	Stability and accuracy assessment of identification of traditional Chinese materia medica using DNA barcoding: a case study on Flos Lonicerae Japonicae.
8/2002	[Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Yao Research Topics

Disease

84	Neoplasms (Cancer) 04/2024 - 06/2007
11	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2010
9	Inflammation (Inflammations) 09/2023 - 05/2012
9	Neoplasm Metastasis (Metastasis) 03/2022 - 06/2007
8	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 07/2011
7	Infections 02/2024 - 01/2012
7	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 07/2010
6	Carcinogenesis 04/2024 - 10/2014
6	Adenocarcinoma 01/2023 - 05/2009
6	Glioma (Gliomas) 10/2021 - 01/2015
5	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2017
5	Aphthous Stomatitis (Aphthous Ulcer) 02/2024 - 01/2022
5	Triple Negative Breast Neoplasms 01/2024 - 01/2017
5	Nasopharyngeal Carcinoma 08/2023 - 01/2017
5	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 03/2018
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 08/2013
5	Carcinoma (Carcinomatosis) 01/2023 - 08/2013
5	Oral Lichen Planus 01/2021 - 02/2011
5	Schizophrenia (Dementia Praecox) 12/2018 - 08/2002
5	Hypoxia (Hypoxemia) 12/2017 - 01/2003
4	Pain (Aches) 01/2023 - 01/2019
4	Fibrosis (Cirrhosis) 01/2022 - 06/2018
4	Hypertension (High Blood Pressure) 08/2021 - 09/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2014 - 02/2010
3	Ulcer 08/2023 - 01/2022
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 08/2017
3	Hypoglycemia (Reactive Hypoglycemia) 07/2022 - 11/2018
3	Reperfusion Injury 01/2022 - 11/2006
3	Heart Failure 01/2021 - 01/2005
3	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 01/2015
3	Memory Disorders (Memory Loss) 01/2020 - 01/2017
3	Cognitive Dysfunction 10/2019 - 08/2017
3	Weight Gain 12/2018 - 08/2002
3	Squamous Cell Carcinoma of Head and Neck 01/2018 - 02/2011
3	Febrile Seizures (Febrile Seizure) 11/2013 - 05/2009
3	Body Weight (Weight, Body) 05/2012 - 08/2002
3	Ischemia 11/2006 - 01/2003
2	Colitis 04/2024 - 05/2012
2	Wounds and Injuries (Trauma) 02/2024 - 07/2018
2	Endometrial Neoplasms (Endometrial Cancer) 12/2023 - 01/2023
2	Postoperative Pain 10/2023 - 01/2022
2	Non-alcoholic Fatty Liver Disease 01/2023 - 11/2020
2	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2016
2	Neuroinflammatory Diseases 01/2023 - 12/2020
2	Mental Disorders (Mental Disorder) 01/2023 - 01/2022
2	Disease Progression 12/2022 - 07/2017

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 08/2023 - 02/2011
20	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2009
14	MicroRNAs (MicroRNA)IBA 10/2022 - 05/2009
11	Messenger RNA (mRNA)IBA 08/2023 - 05/2011
9	Long Noncoding RNAIBA 12/2023 - 10/2014
9	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2011
7	Lovastatin (Mevacor)FDA LinkGeneric 01/2024 - 01/2016
6	AntioxidantsIBA 02/2024 - 02/2005
6	CytokinesIBA 02/2024 - 05/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2002
5	Tyrosine Kinase InhibitorsIBA 08/2021 - 08/2009
5	ChromatinIBA 01/2021 - 10/2014
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 06/2012
5	Phosphotransferases (Kinase)IBA 01/2021 - 08/2009
4	CalciumIBA 08/2023 - 01/2003
4	Ethanol (Ethyl Alcohol)IBA 01/2023 - 12/2020
4	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 08/2002
4	InterleukinsIBA 07/2022 - 06/2018
4	SolutionsIBA 07/2022 - 01/2003
4	Peptides (Polypeptides)IBA 03/2021 - 01/2015
4	Ketamine FDA LinkGeneric 01/2020 - 01/2017
4	Superoxide DismutaseIBA 06/2018 - 04/2003
4	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 08/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 06/2007
3	Thalidomide (Thalomid)FDA Link 02/2024 - 05/2013
3	InterferonsIBA 01/2022 - 05/2015
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 11/2006
3	ParaffinIBA 11/2021 - 02/2016
3	AntigensIBA 11/2021 - 01/2020
3	apatinibIBA 10/2021 - 04/2021
3	Caspase 3 (Caspase-3)IBA 05/2021 - 07/2011
3	CollagenIBA 05/2021 - 06/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 04/2015
3	KATP ChannelsIBA 11/2010 - 02/2005
2	Phenobarbital (Luminal)FDA Link 04/2024 - 01/2020
2	Interleukin-4 (Interleukin 4)IBA 02/2024 - 05/2010
2	Calcium-Binding ProteinsIBA 08/2023 - 05/2009
2	GoldIBA 03/2023 - 01/2022
2	Hormones (Hormone)IBA 01/2023 - 12/2018
2	InflammasomesIBA 01/2023 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2022
2	poly(lactide) (polylactic acid)IBA 01/2022 - 01/2012
2	Capsules (Microcapsules)IBA 01/2022 - 07/2016
2	artemisinin (artemisinine)IBA 01/2022 - 01/2021
2	CarbonIBA 01/2022 - 04/2015

Therapy/Procedure

39	Therapeutics 02/2024 - 05/2010
11	Drug Therapy (Chemotherapy) 10/2023 - 05/2010
7	Immunotherapy 04/2024 - 01/2021
4	Radiotherapy 11/2023 - 05/2018
4	Injections 10/2021 - 02/2018
4	Aftercare (After-Treatment) 08/2021 - 08/2002
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 01/2017
2	Oral Medicine 11/2023 - 01/2022
2	Photothermal Therapy 03/2023 - 07/2016